MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tilray Brands, Inc. - Common Stock (NQ:TLRY)

4.750 +4.750 (+1187400.00%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Tilray Brands, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Tilray's Stock Is Down 45% This Year, and Here's Why It Could Still Go Lower ↗
Investors seeking exposure to the marijuana market may now have a more attractive option to consider. 
Via The Motley Fool
Topics Cannabis
News headline image
Tilray Is Growing 73% Internationally. The Market Is Paying Almost No Attention. Is That a Mistake? ↗
There are good things taking shape at Tilray, but there's one overriding theme that you can't ignore. 
Via The Motley Fool
Topics Cannabis
News headline image
Better Marijuana Stock to Buy Right Now: Tilray or Trulieve? ↗
Trulieve's price has soared this year, while Tilray's has plummeted, but which is the better stock right now? 
Via The Motley Fool
Topics Cannabis
News headline image
The One Market That Could Make or Break Tilray Stock ↗
Most of Tilray's sales come from Canada and the European Union. 
Via The Motley Fool
Topics Cannabis
News headline image
Is Tilray's Brewdog Bet Already Backfiring? Collapsing UK Sales Suggest Yes. ↗
Tilray bought Brewdog on the cheap, but there's a reason why it got such a good price. 
Via The Motley Fool
Topics Cannabis
News headline image
The Single Biggest Cannabis Catalyst in Years Is Rapidly Approaching: 2 Marijuana Stocks to Buy Now ↗
Two of the top multi-state operators have seen their shares jump since reclassifying news came out, but they may no longer be the best cannabis stocks to buy. 
Via The Motley Fool
Topics Cannabis Law Enforcement
News headline image
Tilray Stock Has Crashed 90%. Could Marijuana Rescheduling Spark a Massive Comeback? ↗
Don't hold your breath. 
Via The Motley Fool
Topics Cannabis Government Law Enforcement
News headline image
Tilray Looks Ready for a Breakout -- If 1 Thing Goes Right ↗
The bull case still hinges on legalization's progress. 
Via The Motley Fool
Topics Cannabis
News headline image
If You're a Long-Term Growth Investor, This Is the Sector to Be Focusing On, and It Has Nothing to Do With Artificial Intelligence ↗
The cannabis industry could be on the cusp of significant growth in the coming years. 
Via The Motley Fool
Topics Artificial Intelligence Cannabis
News headline image
Canopy Growth Is Restating Two Years of Financials Before June 15 Earnings -- Here's What CGC Investors Need to Know Right Now ↗
When a company restates its earnings, it often indicates mistakes were made, which can be a troubling issue for a penny stock. 
Via The Motley Fool
Topics Cannabis
News headline image
Canopy Growth's Stock Just Dropped -- Here's Why I'm Still Not Buying ↗
It's unfitting that the marijuana seller has "growth" in its name. 
Via The Motley Fool
Topics Cannabis
News headline image
It's Been 5 Years Since Tilray Merged With Aphria to Create a "Global Cannabis Leader." Here's How It's Done Since Then ↗
Tilray's business has gotten bigger over the years, but it continues to struggle with achieving profitability. 
Via The Motley Fool
Topics Cannabis
News headline image
1 Wall Street Analyst Thinks Tilray Will Soar Nearly 75%. Is It a Buy Now? ↗
International growth could make up for a lack of U.S. legalization progress 
Via The Motley Fool
Topics Cannabis
News headline image
Is Tilray the Best Value Play in the $7.4 Billion Cannabis Beverage Market? ↗
Or is it just a value trap? 
Via The Motley Fool
Topics Cannabis Law Enforcement
News headline image
Why Tilray's Marijuana Rescheduling Sizzle Has Fizzled ↗
Most regulatory headwinds remain for cannabis companies like Tilray. 
Via The Motley Fool
Topics Cannabis
News headline image
Tilray Brands to Expand Into the U.S. Marijuana Market? Why You Shouldn't Count on That Anytime Soon ↗
Marijuana rescheduling may have taken place in the U.S., but that doesn't mean legalization will happen anytime soon. 
Via The Motley Fool
Topics Cannabis Government Law Enforcement
News headline image
Marijuana Rescheduling Has Arrived. Don't Make This Mistake ↗
The Trump administration recently rescheduled medical marijuana from a Schedule I to Schedule III substance. 
Via The Motley Fool
Topics Cannabis Government
News headline image
This Trump Policy Shift Could Be a Game Changer for Cannabis Stocks: 2 Stocks to Watch Now
A federal shift toward Schedule 3 may boost cannabis stocks, even as recreational use remains restricted. 
Via Barchart.com
Topics Cannabis Government Law Enforcement
News headline image
Is Tilray a Textbook Example of a Value Trap? ↗
Tilray doesn't fit squarely into the value trap or value stock categories. 
Via The Motley Fool
Topics Cannabis
News headline image
The Cannabis Sector's Billion-Dollar Tax Cut ↗
Via MarketBeat
Topics Cannabis
News headline image
Tilray Stock Jumps As Trump Administration Eyes Marijuana Reclassification: Report ↗
Shares of Tilray Brands (NASDAQ: TLRY) are trading higher Wednesday afternoon following breaking news of a potential major regulatory shift. 
Via Benzinga
Topics Cannabis Government
News headline image
1 Wall Street Analyst Says Tilray Stock Could Jump Over 40%. Should You Believe It? ↗
Tilray is showing signs of improvement. But a 40% jump over the next 12 months might be a stretch. 
Via The Motley Fool
Topics Cannabis
News headline image
Here's What to Expect From Air Products and Chemicals' Next Earnings Report
Air Products and Chemicals is expected to release its fiscal second-quarter earnings this month, and analysts project a double-digit earnings growth. 
Via Barchart.com
Topics Cannabis ETFs
News headline image
Tilray Stock Pops on New Trump-Driven Cannabis Hopes. Should You Chase the Rally?
Tilray shares rally as Trump urges the DOJ to quickly reclassify cannabis as a Schedule III drug. Options pricing suggests TLRY stock could rip higher through mid-September. 
Via Barchart.com
Topics Cannabis Government
News headline image
Apple's Q2 2026 Earnings: What to Expect
Apple is expected to announce its second-quarter results this month, and analysts are projecting a double-digit rise in its EPS 
Via Barchart.com
Topics Cannabis ETFs
News headline image
The 420 Failure: Here's the Real Reason Tilray Brands Has Been a Horrible Investment Despite Operating in a Legal Marijuana Market ↗
The cannabis stock has lost around 96% of its value over the past five years. 
Via The Motley Fool
Topics Cannabis
News headline image
Why Is Tilray Brands Stock Falling Wednesday? ↗
Tilray (TLRY) shares dip on a $180M equity program. Explore its global push into U.K. healthcare, BrewDog growth, and U.S. market strategy. 
Via Benzinga
News headline image
Tilray Posted Record Numbers Last Quarter, but Where the Bulk of Its Growth Has Come From Over the Past 4 Years Might Surprise You ↗
Tilray has leaned on acquisitions heavily over the past few years in order to grow its business. 
Via The Motley Fool
Topics Cannabis
News headline image
Why Tilray Stock Got Hammered in March ↗
What's another month of struggle for a company in the cannabis industry? 
Via The Motley Fool
Topics Cannabis
News headline image
What's Going On With Tilray Brands Stock On Wednesday? ↗
Tilray shares gained after launching a high-potency cannabis brand, with innovation and strong momentum outweighing mixed technical signals. 
Via Benzinga
Topics Cannabis
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story